Novartis to acquire Avidity Biosciences for about $12 billion
Deal to expand rare disease treatments Avidity to separate early-stage cardiology programs into new company Acquisition to help Novartis gain stronger foothold in US Oct 26 (Reuters) – Swiss drugmaker Novartis (NOVN.S), opens new tab on Sunday said it agreed…